🇺🇸 FDA
Patent

US 10300072

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

granted A61KA61K31/4178A61K31/4184

Quick answer

US patent 10300072 (Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities) held by Almirall, S.A. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4178, A61K31/4184, A61K31/423, A61K31/428